Cargando…

Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone

OBJECTIVE: Reports on the association between growth hormone (GH) therapy and cardiovascular risk factors in children are limited. This study aimed to evaluate carotid intima-media thickness (cIMT) in children treated with recombinant human GH (rhGH) and assess the effects of rhGH therapy and change...

Descripción completa

Detalles Bibliográficos
Autores principales: Saygılı, Seha, Kocaağa, Mehmet, Kaya, Gamze, Şükür, Mine, Baş, Firdevs, Poyrazoğlu, Şükran, Bundak, Rüveyde, Darendeliler, Feyza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976170/
https://www.ncbi.nlm.nih.gov/pubmed/36416456
http://dx.doi.org/10.4274/jcrpe.galenos.2022.2022-8-19
_version_ 1784899010836824064
author Saygılı, Seha
Kocaağa, Mehmet
Kaya, Gamze
Şükür, Mine
Baş, Firdevs
Poyrazoğlu, Şükran
Bundak, Rüveyde
Darendeliler, Feyza
author_facet Saygılı, Seha
Kocaağa, Mehmet
Kaya, Gamze
Şükür, Mine
Baş, Firdevs
Poyrazoğlu, Şükran
Bundak, Rüveyde
Darendeliler, Feyza
author_sort Saygılı, Seha
collection PubMed
description OBJECTIVE: Reports on the association between growth hormone (GH) therapy and cardiovascular risk factors in children are limited. This study aimed to evaluate carotid intima-media thickness (cIMT) in children treated with recombinant human GH (rhGH) and assess the effects of rhGH therapy and changes in serum carbohydrate metabolism, lipid profile and adipocytokines on cIMT. METHODS: Seventy-one isolated idiopathic GH deficiency (GHD) children and 44 age- and sex-matched healthy controls were enrolled in this study. The study group was divided into two subgroups according to insulin resistance (IR) on oral glucose tolerance tests. Insulin secretion [homeostatic model assessment (HOMA) B, total insulin] and sensitivity (HOMA-IR, QUICKI, Matsuda) indices were calculated. cIMT was measured and the standard deviation scores (SDS) were calculated. Associations between cIMT-SDS and insulin secretion and sensitivity indices, serum lipid levels, adipocytokines (leptin, resistin, ghrelin), and other rhGH treatment-related factors were evaluated. RESULTS: cIMT-SDS was increased in GHD children treated with rhGH compared to the controls [0.02 (2.27) vs. -1.01 (1.63), p=0.003]. cIMT-SDS did not differ between those children on rhGH treatment with or without IR. High cIMT-SDS was significantly associated with higher serum ghrelin levels and lower serum high density lipoprotein (HDL) levels (β=0.491, p=0.001 and β=-0.027, p=0.017), but not with BMI-SDS, blood pressure, insulin secretion and sensitivity indices, or the dose and duration of rhGH therapy. CONCLUSION: Our findings showed that GHD children treated with rhGH have increased cIMT. Alterations in carbohydrate metabolism were not associated with cIMT in children treated with rhGH. GH therapy per se appears to be associated with this increased cIMT but causality should be elucidated in further studies. cIMT also appears to be associated with higher ghrelin and lower HDL levels.
format Online
Article
Text
id pubmed-9976170
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-99761702023-03-02 Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone Saygılı, Seha Kocaağa, Mehmet Kaya, Gamze Şükür, Mine Baş, Firdevs Poyrazoğlu, Şükran Bundak, Rüveyde Darendeliler, Feyza J Clin Res Pediatr Endocrinol Original Article OBJECTIVE: Reports on the association between growth hormone (GH) therapy and cardiovascular risk factors in children are limited. This study aimed to evaluate carotid intima-media thickness (cIMT) in children treated with recombinant human GH (rhGH) and assess the effects of rhGH therapy and changes in serum carbohydrate metabolism, lipid profile and adipocytokines on cIMT. METHODS: Seventy-one isolated idiopathic GH deficiency (GHD) children and 44 age- and sex-matched healthy controls were enrolled in this study. The study group was divided into two subgroups according to insulin resistance (IR) on oral glucose tolerance tests. Insulin secretion [homeostatic model assessment (HOMA) B, total insulin] and sensitivity (HOMA-IR, QUICKI, Matsuda) indices were calculated. cIMT was measured and the standard deviation scores (SDS) were calculated. Associations between cIMT-SDS and insulin secretion and sensitivity indices, serum lipid levels, adipocytokines (leptin, resistin, ghrelin), and other rhGH treatment-related factors were evaluated. RESULTS: cIMT-SDS was increased in GHD children treated with rhGH compared to the controls [0.02 (2.27) vs. -1.01 (1.63), p=0.003]. cIMT-SDS did not differ between those children on rhGH treatment with or without IR. High cIMT-SDS was significantly associated with higher serum ghrelin levels and lower serum high density lipoprotein (HDL) levels (β=0.491, p=0.001 and β=-0.027, p=0.017), but not with BMI-SDS, blood pressure, insulin secretion and sensitivity indices, or the dose and duration of rhGH therapy. CONCLUSION: Our findings showed that GHD children treated with rhGH have increased cIMT. Alterations in carbohydrate metabolism were not associated with cIMT in children treated with rhGH. GH therapy per se appears to be associated with this increased cIMT but causality should be elucidated in further studies. cIMT also appears to be associated with higher ghrelin and lower HDL levels. Galenos Publishing 2023-03 2023-02-27 /pmc/articles/PMC9976170/ /pubmed/36416456 http://dx.doi.org/10.4274/jcrpe.galenos.2022.2022-8-19 Text en ©Copyright 2023 by Turkish Pediatric Endocrinology and Diabetes Society | The Journal of Clinical Research in Pediatric Endocrinology published by Galenos Publishing House. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Saygılı, Seha
Kocaağa, Mehmet
Kaya, Gamze
Şükür, Mine
Baş, Firdevs
Poyrazoğlu, Şükran
Bundak, Rüveyde
Darendeliler, Feyza
Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title_full Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title_fullStr Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title_full_unstemmed Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title_short Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone
title_sort increased carotid intima-media thickness and its association with carbohydrate metabolism and adipocytokines in children treated with recombinant growth hormone
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976170/
https://www.ncbi.nlm.nih.gov/pubmed/36416456
http://dx.doi.org/10.4274/jcrpe.galenos.2022.2022-8-19
work_keys_str_mv AT saygılıseha increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT kocaagamehmet increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT kayagamze increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT sukurmine increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT basfirdevs increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT poyrazoglusukran increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT bundakruveyde increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone
AT darendelilerfeyza increasedcarotidintimamediathicknessanditsassociationwithcarbohydratemetabolismandadipocytokinesinchildrentreatedwithrecombinantgrowthhormone